Lisa Peraza
Patrimonio netto: 107 550 $ in data 30/06/2026
Patrimonio netto: 107 550 $ in data 30/06/2026
Lisa Peraza is Vice President-Finance at Connect Biopharma Holdings Ltd. since 2024.
Formerly, Ms. Peraza was Chief Accounting Officer & Vice President at Heron Therapeutics, Inc. from 2020 to 2024 and Executive Director & Controller at Ardea Biosciences, Inc. from 2008 to 2014.
Education includes undergraduate studies at the University of California, Santa Barbara.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 16/03/2026 | 45.189 ( 0,08% ) | 107 550 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Direttore Finanziario/CFO | 13/09/2024 |
| Società | Posizione | Fine |
|---|---|---|
| HERON THERAPEUTICS, INC. | Direttore Amministrativo | - |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Direttore/Membro del Consiglio | 01/03/2014 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Heron Therapeutics, Inc.
Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Connect Biopharma Holdings Ltd.
Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale